Reolysin

Results: 19



#Item
1CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for

CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for

Add to Reading List

Source URL: www.ctc.usyd.edu.au

Language: English - Date: 2016-03-21 02:14:55
2FINAL FOR DISTRIBUTION PSIOXUS THERAPEUTICS RAISES A £25M SERIES C INVESTMENT TO PROGRESS ONCOLYTIC VIRUS PLUS CHECKPOINT INHIBITOR COMBINATION STUDY IN METASTATIC COLORECTAL CANCER OXFORD, UK – 19 May 2015 – PsiOxu

FINAL FOR DISTRIBUTION PSIOXUS THERAPEUTICS RAISES A £25M SERIES C INVESTMENT TO PROGRESS ONCOLYTIC VIRUS PLUS CHECKPOINT INHIBITOR COMBINATION STUDY IN METASTATIC COLORECTAL CANCER OXFORD, UK – 19 May 2015 – PsiOxu

Add to Reading List

Source URL: www.psioxus.com

Language: English - Date: 2015-05-19 03:49:40
3Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer

Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2013-07-18 09:56:35
4This Week in Virology with Vincent Racaniello, Ph.D. Episode 131: A REOstat for cancer Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove Guest: Brad Thompson, CEO of Oncolytics Biotech

This Week in Virology with Vincent Racaniello, Ph.D. Episode 131: A REOstat for cancer Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove Guest: Brad Thompson, CEO of Oncolytics Biotech

Add to Reading List

Source URL: www.twiv.tv

Language: English - Date: 2012-11-29 12:48:47
5Published OnlineFirst November 24, 2010; DOI:[removed].CCR[removed]A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer Martijn P. Lolkema, H

Published OnlineFirst November 24, 2010; DOI:[removed].CCR[removed]A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer Martijn P. Lolkema, H

Add to Reading List

Source URL: www.oncolyticsbiotech.com

Language: English - Date: 2013-12-24 04:35:54
6Published OnlineFirst March 9, 2010; DOI:[removed].CAN[removed]Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic Chandini M. Thirukkumaran, Michael J. Nodwell, Kensuke

Published OnlineFirst March 9, 2010; DOI:[removed].CAN[removed]Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic Chandini M. Thirukkumaran, Michael J. Nodwell, Kensuke

Add to Reading List

Source URL: www.oncolyticsbiotech.com

Language: English - Date: 2013-12-24 04:11:08
7DOI:[removed].CCR[removed]A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer Laura Vidal, Hardev S. Pandha, Timothy A. Yap, et al. Clin Cancer Res 2008;14:[removed]

DOI:[removed].CCR[removed]A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer Laura Vidal, Hardev S. Pandha, Timothy A. Yap, et al. Clin Cancer Res 2008;14:[removed]

Add to Reading List

Source URL: www.oncolyticsbiotech.com

Language: English - Date: 2013-12-23 12:35:03
8Oncolytic Reovirus in Canine Mast Cell Tumor Chung Chew Hwang1, Saori Umeki1, Masahito Kubo2, Toshiharu Hayashi2, Hiroshi Shimoda3, Masami Mochizuki4, Ken Maeda3, Kenji Baba5, Hiroko Hiraoka5, Matt Coffey6, Masaru Okuda1

Oncolytic Reovirus in Canine Mast Cell Tumor Chung Chew Hwang1, Saori Umeki1, Masahito Kubo2, Toshiharu Hayashi2, Hiroshi Shimoda3, Masami Mochizuki4, Ken Maeda3, Kenji Baba5, Hiroko Hiraoka5, Matt Coffey6, Masaru Okuda1

Add to Reading List

Source URL: www.oncolyticsbiotech.com

Language: English - Date: 2013-12-24 04:48:54
9Published OnlineFirst September 22, 2009; DOI:[removed].CCR[removed]Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma Hardev S. Pandha, Lucy Heinemann, Guy R. Simp

Published OnlineFirst September 22, 2009; DOI:[removed].CCR[removed]Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma Hardev S. Pandha, Lucy Heinemann, Guy R. Simp

Add to Reading List

Source URL: www.oncolyticsbiotech.com

Language: English - Date: 2013-12-23 12:38:23
10Published OnlineFirst October 6, 2010; DOI:[removed].CCR[removed]REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer Charles Comins, James Spicer, Andrew Protheroe, et

Published OnlineFirst October 6, 2010; DOI:[removed].CCR[removed]REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer Charles Comins, James Spicer, Andrew Protheroe, et

Add to Reading List

Source URL: www.oncolyticsbiotech.com

Language: English - Date: 2013-12-23 11:19:21